Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2014

View Archived Issues

Genetic screening to identify novel small-molecule drug targets to overcome drug resistance

Perlstein Lab raises funds for orphan disease drug discovery

Sterigenics completes acquisition of Nordion

Camp Nine changes name to Relmada Therapeutics

Development of a new human monoclonal antibody effective against NiV

ProStrakan completes acquisition of Archimedes Pharma

Data show high efficacy for CF-101 in rheumatoid arthritis and psoriasis

EDP-239 advances into combination studies with alisporivir

Sanofi licenses use of GLAAS platform to develop food allergy therapy

Biodesy enters into research collaboration with Amgen

Eisai reports topline phase III data for eribulin in non-small cell lung cancer

Genentech presents novel series of pan-Pim kinase inhibitors: candidate disclosed

Otsuka Pharmaceutical recaps milestones of first quarter of fiscal 2014

Transplant Genomics reports the development of a transplant surveillance program

Preliminary results from validation study of Oncotype DX prostate cancer test

Lundbeck profiles pipeline progress of second quarter 2014

Merck & Co. patents new BTK inhibitors

Novel anticancer marine macrolides presented by French team

Catalyst Pharmaceutical provides update on phase III Firdapse study

India CSIR discloses new agents for diabetes and dyslipidemia

miRNA biomarkers identified for oesophageal squamous cell carcinoma detection and prognosis

GlaxoSmithKline divulges novel Lp-PLA2 inhibitors

HDAC8 inhibitors patented by U.S. team

Organizations join forces to combat Ebola

Mirati's mocetinostat awarded orphan drug designation for DLBCL

The ALS Association awards 21 new research grants

TapImmune confirms new clinical trial of folate receptor alpha peptide antigens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...